Schizophrenia & Psychosis at AAPP 2027 Annual Meeting
4 sessions on schizophrenia & psychosis · April 4–7, 2027, Louisville, KY. Compare schizophrenia & psychosis at other meetings →
Sunday, April 4
12:15–13:15 · Lecture
The Cycle of Chaos to Hope: Navigating Schizophrenia as a Mother and Caregiver
A keynote by a mother and advocate describing her family's experience with a son's schizophrenia, and how psychiatric pharmacists can partner with family caregivers to build trust, improve communication and support recovery.
Monday, April 5
14:50–15:50 · Lecture · Member-Submitted Program
Antipsychotic Pharmacogenomics: Consensus Guideline Updates and Clinical Application
Reviews current consensus guidelines on pharmacogenomic testing for antipsychotic therapy, key gene-drug interactions, and which patients may benefit most. Uses real-world clinical scenarios to show how to apply results to treatment decisions.
Antipsychotic Prescribing · Pharmacogenomics & Precision Psychiatry
Tuesday, April 6
09:15–10:15 · Lecture · Clinical Application Series
Psychosis in the Context of Substance Use: Primary Diagnosis or Substance Effect?
Aaron Salwan · Abraham Thengampallil
Online course on telling substance-induced psychosis apart from a primary psychotic disorder. Covers substances linked to psychosis, treatment approaches including antipsychotic management, and the psychiatric pharmacist's role.
Antipsychotic Prescribing · Measurement-Based Care & Diagnosis · Substance Use Disorders
13:30–14:30 · Lecture · Member-Submitted Program
AI-Induced Psychosis: Are We There Yet?
Examines reported cases where interactions with AI chatbots were linked to onset or worsening of psychosis, including the evidence, legal and ethical implications, and the role of LLM guardrails in reducing risk.
Other topics at this meeting
Drug Interactions & Safety 5Practice, Policy & Workforce 5Medical Comorbidity & C-L Psychiatry 5Antipsychotic Prescribing 4Anxiety Disorders 4Collaborative & Integrated Care 4Education & Training 4Deprescribing & Polypharmacy 3Depression 3Measurement-Based Care & Diagnosis 3Pharmacogenomics & Precision Psychiatry 3Child & Adolescent 2